GlassScriptPhysician profile
Mihai Jipa
NPI 1033172820
$4,518.17
in general payments reported to CMS, 2019-2025
48 companies · $1,603 in 2025
The $1,603 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2021: $22.19 · 2022: $413 · 2023: $949 · 2024: $1,408 · 2025: $1,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,960.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $564.33 | 2021-2025 | |
| Amgen INC. | $389.70 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $349.55 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $310.75 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $297.26 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $281.72 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $193.68 | 2022-2025 | |
| Viiv Healthcare Company | $178.81 | 2022-2025 | Apretude |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.60 | 2024-2025 | Xifaxan |
| Astellas Pharma US INC | $147.12 | 2022-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $131.03 | 2022-2025 | Gardasil 9, Capvaxive, Dificid |
| Glaxosmithkline, LLC. | $127.24 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Xeris Pharmaceuticals, INC. | $127.09 | 2024-2025 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $95.87 | 2023-2024 | Xarelto, Spravato |
| Ibsa Pharma INC. | $84.81 | 2024-2025 | Licart, Tirosint, Flector |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $83.35 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.35 | 2022-2025 | Jardiance, Tradjenta, Glyxambi |
| Boston Scientific Corporation | $71.20 | 2025 | Bodyguardian, Cds - Other |
| Kowa Pharmaceuticals America, INC. | $69.46 | 2023-2025 | Zoryve, Seglentis |
| Corcept Therapeutics | $57.11 | 2025 | Korlym |
| Otsuka America Pharmaceutical, INC. | $52.86 | 2024-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $48.02 | 2023-2025 | Eliquis, Camzyos |
| Phathom Pharmaceuticals, INC. | $46.48 | 2024-2025 | Voquezna |
| Abbott Laboratories | $42.92 | 2022-2023 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $36.86 | 2024-2025 | |
| Dexcom, INC. | $33.03 | 2024-2025 | Dexcom G6 Transmitter |
| Averitas Pharma INC. | $31.42 | 2024 | Qutenza |
| Edwards Lifesciences Corporation | $30.40 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biohaven Pharmaceutical Holding Company LTD. | $28.64 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $28.36 | 2025 | |
| Axsome Therapeutics, INC. | $27.48 | 2023 | Sunosi |
| Ars Pharmaceuticals Operations, INC. | $26.20 | 2025 | Neffy |
| Inspire Medical Systems, INC. | $25.23 | 2025 | Inspire |
| Ultragenyx Pharmaceutical INC. | $23.35 | 2024 | Crysvita |
| Optinose US, INC. | $22.73 | 2024 | |
| Mylan Specialty L.P. | $22.50 | 2023 | Yupelri |
| Antares Pharma, INC. | $20.89 | 2025 | Xyosted |
| Amneal Pharmaceuticals LLC | $19.04 | 2023 | Unithroid |
| Becton, Dickinson and Company | $18.26 | 2024 | Bd Onclarity |
| Lundbeck LLC | $18.07 | 2025 | Rexulti |
| Horizon Therapeutics Plc | $16.55 | 2023 | Krystexxa |
| Dynavax Technologies Corporation | $16.38 | 2025 | Heplisav-B |
| Kaleo, INC. | $15.40 | 2023 | Auvi-Q |
| Actelion Pharmaceuticals US, INC. | $15.30 | 2025 | Opsumit, Uptravi |
| Exeltis, USA INC. | $15.23 | 2025 | Slynd |
| Sanofi-Aventis U.S. LLC | $14.85 | 2024 | |
| Noven Therapeutics, LLC | $13.39 | 2024 | Xelstrym |
| Takeda Pharmaceuticals U.S.A., INC. | $13.30 | 2023 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihai Jipa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.